Trial Information

Does Restless Legs Syndrome have you going in circles?

If you have been diagnosed with moderate to severe Restless Legs Syndrome (RLS) or believe you are experiencing RLS symptoms, the CONCORD clinical research study may be right for you.

Why is the CONCORD study taking place?

The drug being evaluated in the CONCORD study has been approved by the U.S. Food and Drug Administration (FDA) at a specific dose strength for the treatment of RLS.

The CONCORD study is being done to learn more about the drug when it is given in two investigational lower dose strengths, as well as the approved dose strength, when compared with placebo. A placebo looks like the approved RLS medication but contains no active ingredients.

The two lower dose strengths of the medication are considered investigational in this study because they are not yet approved by the FDA for the treatment of RLS.

Who can participate in the CONCORD study?

You may be eligible for further screening for the CONCORD study if you are:

At least 18 years of age
Experiencing RLS symptoms for at least 15 nights in the month before beginning the study or, if currently receiving RLS treatment, 15 nights in the month before beginning treatment

All study-related visits, tests, and study drug will be provided to participants at no cost. In addition, reimbursement for time and travel may be provided.

Please contact the research center for additional information.

Charlottesville Medical Research
325 Winding River Lane, Suite 102
Charlottesville, VA 22911
Phone: 434-817-2442

View Map

Research Center Information: Charlottesville Medical Research

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.